Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 27, 2025
NSP7 Molecular Degrader Attenuates Coronaviral Infection Through the β-TrCP1/FBXO5 AxisYao Tong, Travis B Lear, Ferhan Tuncer, et al.
JCI Insight|October 4, 2019
KIAA0317 regulates pulmonary inflammation through SOCS2 degradationTravis B Lear, Alison C McKelvey, John W Evankovich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2022
Cross-Regulation of F-Box Protein FBXL2 with T-bet and TNF-α during Acute and Chronic Lung Allograft RejectionAntu Das, Xingan Wang, Jianxin Wei, et al.
Critical Care Medicine|October 22, 2019
Host-Response Subphenotypes Offer Prognostic Enrichment in Patients With or at Risk for Acute Respiratory Distress SyndromeGeorgios D Kitsios, Libing Yang, Dimitris V Manatakis, et al.
Nature Communications|August 5, 2025
SON-dependent nuclear speckle rehabilitation alleviates proteinopathiesWilliam Dion, Yuren Tao, Maci Chambers, et al.
Nature Communications|July 22, 2024
Targeted degradation of extracellular mitochondrial aspartyl-tRNA synthetase modulates immune responsesBenjamin S Johnson, Daniela Farkas, Rabab El-Mergawy, et al.
Nature Medicine|September 21, 2010
Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumoniaNancy B Ray, Lakshmi Durairaj, Bill B Chen, et al.
Science Advances|June 4, 2025
Inhibition of virally induced TFEB proteasomal degradation as a host-centric therapeutic approach for coronaviral infectionTravis B Lear, Mads B Larsen, Bo Lin, et al.
Plos One|October 24, 2024
Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patientsCarlo J Iasella, Stefanie J Hannan, Emily J Lyons, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2022
CD4<sup>+</sup> T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-DependentIulia Popescu, Mark E Snyder, Carlo J Iasella, et al.
Pageof 7